Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Iovance Biotherapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 286
- −6 vs. Q2 2024
- Shares held
- 235.3M
- +23.9M (+11.3%) vs. Q2 2024
- Total value
- $2.21B
- +$516.5M (+30.5%) vs. Q2 2024
- New holders
- 40
- 107 more added
- Sold out
- 46
- 84 more reduced
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jennison Associates LLC | 0 | $0 | 0.00% | −58,084−100.0% | Sold out |
| Kettle Hill Capital Management, LLC | 0 | $0 | 0.00% | −41,906−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −31,360−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −23,767−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −18,770−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −16,980−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −16,939−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −16,067−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −15,831−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −14,106−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,483−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,477−100.0% | Sold out |
| Abacus Planning Group, Inc. | 0 | $0 | 0.00% | −10,284−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −10,242−100.0% | Sold out |
| Prime Capital Investment Advisors, LLC | 0 | $0 | 0.00% | −10,021−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,015−100.0% | Sold out |
| ORG Partners LLC | 0 | $0 | 0.00% | −3,974−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −3,831−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −1,915−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −1,777−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −850−100.0% | Sold out |
| Ibex Wealth Advisors | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −168−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| ICA Group Wealth Management, LLC | – | – | – | – | Not filed |
| Institutional & Family Asset Management, LLC | – | – | – | – | Not filed |